Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 18 and 75 years of age
- People who have been diagnosed with invasive breast cancer confirmed by a pathology test (such as a biopsy)
- People whose breast cancer is at a certain stage — not spread to distant parts of the body, and meeting specific size and lymph node criteria (confirm with trial site)
- People whose general health and ability to carry out daily activities meets a specific medical rating known as ECOG 0 or 1, meaning generally active and able to care for oneself (confirm with trial site)
- People with cancer in one breast only, not both
- People whose heart is pumping blood effectively, with a specific heart function measurement of 50% or above
- People whose blood counts and kidney function fall within specific ranges — including white blood cell count, neutrophil count, platelet count, haemoglobin levels, and a kidney marker called serum creatinine (confirm exact values with trial site)
- People who are not planning to have breast reconstruction surgery
Who may not be able to join:
- People whose cancer has grown into the skin of the breast
- People with a widespread pattern of tiny calcium deposits throughout the breast linked to cancer (known as diffuse malignant microcalcifications)
- People who are pregnant or breastfeeding at the time of the trial
- People who have had another type of primary cancer in the past
- People with serious heart or lung conditions, liver or kidney disease, or other significant ongoing health conditions
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shicheng Su, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phone: +86 13631304227
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Wound Complication Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.